JP6697380B2 - 多能性幹細胞の有用性および安全性を特徴付けるための初期発生ゲノムアッセイ - Google Patents

多能性幹細胞の有用性および安全性を特徴付けるための初期発生ゲノムアッセイ Download PDF

Info

Publication number
JP6697380B2
JP6697380B2 JP2016519572A JP2016519572A JP6697380B2 JP 6697380 B2 JP6697380 B2 JP 6697380B2 JP 2016519572 A JP2016519572 A JP 2016519572A JP 2016519572 A JP2016519572 A JP 2016519572A JP 6697380 B2 JP6697380 B2 JP 6697380B2
Authority
JP
Japan
Prior art keywords
genes
gene
early
stem cell
pluripotent stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016519572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016532435A5 (https=
JP2016532435A (ja
Inventor
アレクサンダー マイスナー
アレクサンダー マイスナー
アレクサンダー ツァンコフ
アレクサンダー ツァンコフ
ヴェロニカ アコピアン
ヴェロニカ アコピアン
Original Assignee
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ filed Critical プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ
Publication of JP2016532435A publication Critical patent/JP2016532435A/ja
Publication of JP2016532435A5 publication Critical patent/JP2016532435A5/ja
Application granted granted Critical
Publication of JP6697380B2 publication Critical patent/JP6697380B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2016519572A 2013-06-10 2014-06-09 多能性幹細胞の有用性および安全性を特徴付けるための初期発生ゲノムアッセイ Active JP6697380B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361833092P 2013-06-10 2013-06-10
US61/833,092 2013-06-10
PCT/US2014/041513 WO2014200905A2 (en) 2013-06-10 2014-06-09 Early developmental genomic assay for characterizing pluripotent stem cell utility and safety

Publications (3)

Publication Number Publication Date
JP2016532435A JP2016532435A (ja) 2016-10-20
JP2016532435A5 JP2016532435A5 (https=) 2017-07-20
JP6697380B2 true JP6697380B2 (ja) 2020-05-20

Family

ID=52022907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016519572A Active JP6697380B2 (ja) 2013-06-10 2014-06-09 多能性幹細胞の有用性および安全性を特徴付けるための初期発生ゲノムアッセイ

Country Status (4)

Country Link
US (2) US11085067B2 (https=)
EP (1) EP3008229B1 (https=)
JP (1) JP6697380B2 (https=)
WO (1) WO2014200905A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3156477B1 (en) 2014-06-16 2023-04-19 Nikon Corporation Method and apparatus for determining a maturity of a cell included in a target colony
WO2018052224A1 (ko) 2016-09-13 2018-03-22 한국전자통신연구원 영상 부호화/복호화 방법, 장치 및 비트스트림을 저장한 기록 매체
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
US11603563B2 (en) * 2017-06-10 2023-03-14 Shimadzu Corporation Method of predicting differentiation potential of iPS cells into cartilage cells based on gene expression profiles
KR20200064077A (ko) * 2017-09-01 2020-06-05 오리그3엔, 인코포레이티드 Ipsc-유래 분비단백체 조성물, 및 관련된 시스템 및 방법
JP7173496B2 (ja) * 2017-10-20 2022-11-16 国立大学法人大阪大学 心筋細胞への分化指向性を有する多能性幹細胞を選抜するための方法
CN113646424A (zh) * 2019-03-29 2021-11-12 富士胶片株式会社 具有分化成特定细胞的能力的多能干细胞的制造方法及其应用
WO2021095798A1 (ja) * 2019-11-15 2021-05-20 公立大学法人横浜市立大学 未分化マーカー遺伝子高感度検出法
EP4092107A4 (en) * 2020-01-16 2023-12-06 FUJIFILM Corporation METHOD FOR PRODUCING PLURIPOTENT STEM CELLS WITH CAPACITY OF DIFFERENTIATION INTO SPECIFIC CELLS AND USE THEREOF
US10968493B1 (en) * 2020-03-12 2021-04-06 New England Biolabs, Inc. Rapid diagnostic test using colorimetric LAMP
EP4148139A4 (en) * 2020-06-19 2023-11-08 FUJIFILM Corporation BIOMARKER IDENTIFICATION METHODS AND CELL MANUFACTURING METHODS
EP3940704A1 (en) * 2020-07-14 2022-01-19 Koninklijke Philips N.V. Method for determining the differentiation state of a stem cell
CN112575010B (zh) * 2020-12-14 2022-11-08 云南农业大学 山药不同组织荧光定量的内参基因及其引物与应用
EP4500537A2 (en) * 2022-03-25 2025-02-05 The Penn State Research Foundation Analysis of genomic word frameworks on genomic methylation data
WO2023201361A1 (en) * 2022-04-15 2023-10-19 Aspen Neuroscience, Inc. Methods of classifying the differentiation state of cells and related compositions of differentiated cells

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US548257A (en) 1895-10-22 Hay rake and loader
US4963489A (en) 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
CA2040503A1 (en) 1990-04-25 1991-10-26 Gene-Trak Systems Selective amplification system using q beta replicase
EP0834575B1 (en) 1990-12-06 2001-11-28 Affymetrix, Inc. (a Delaware Corporation) Identification of nucleic acids in samples
KR100249110B1 (ko) 1992-05-06 2000-04-01 다니엘 엘. 캐시앙 핵산 서열 증폭 방법, 이에 이용되는 조성물 및 키트
AU4543193A (en) 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
US5672346A (en) 1992-07-27 1997-09-30 Indiana University Foundation Human stem cell compositions and methods
ES2157225T3 (es) 1992-10-09 2001-08-16 Advanced Tissue Sciences Inc Celulas hepaticas de reserva.
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US6136540A (en) 1994-10-03 2000-10-24 Ikonisys Inc. Automated fluorescence in situ hybridization detection of genetic abnormalities
US5952172A (en) 1993-12-10 1999-09-14 California Institute Of Technology Nucleic acid mediated electron transfer
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6379897B1 (en) 2000-11-09 2002-04-30 Nanogen, Inc. Methods for gene expression monitoring on electronic microarrays
US5622826A (en) 1994-12-22 1997-04-22 Houston Advanced Research Center Method for immobilization of molecules on platinum solid support surfaces
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US5968740A (en) 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
US5569588A (en) 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
US5994619A (en) 1996-04-01 1999-11-30 University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus Production of chimeric bovine or porcine animals using cultured inner cell mass cells
CA2276462C (en) 1996-12-31 2007-06-12 High Throughput Genomics, Inc. Multiplexed molecular analysis system apparatus and method
US5945577A (en) 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6642433B1 (en) 1997-05-15 2003-11-04 Trillium Therapeutics Inc. Fgl-2 knockout mice
ATE477850T1 (de) 1998-01-12 2010-09-15 Massachusetts Inst Technology Vorrichtung zur mikrotestdurchführung
US6893877B2 (en) 1998-01-12 2005-05-17 Massachusetts Institute Of Technology Methods for screening substances in a microwell array
US6235473B1 (en) 1998-07-02 2001-05-22 Orchid Biosciences, Inc. Gene pen devices for array printing
CA2398107C (en) 2000-01-28 2013-11-19 Althea Technologies, Inc. Methods for analysis of gene expression
WO2001061054A2 (en) 2000-02-18 2001-08-23 Board Of Trustees Of The Leland Stanford Junior University Apparatus and methods for parallel processing of micro-volume liquid reactions
CN1404415A (zh) 2000-02-22 2003-03-19 基因谱公司 微阵列制造技术及设备
US7157227B2 (en) 2000-03-31 2007-01-02 University Of Louisville Research Foundation Microarrays to screen regulatory genes
JP2004504834A (ja) 2000-08-01 2004-02-19 イスム　リサーチ　ディベロップメント　カンパニー 胚性細胞の定方向分化
US6902702B1 (en) 2000-08-16 2005-06-07 University Health Network Devices and methods for producing microarrays of biological samples
EP1390497A2 (en) 2001-05-25 2004-02-25 Genset Human cdnas and proteins and uses thereof
US6902900B2 (en) 2001-10-19 2005-06-07 Prolico, Llc Nucleic acid probes and methods to detect and/or quantify nucleic acid analytes
US20030113910A1 (en) 2001-12-18 2003-06-19 Mike Levanduski Pluripotent stem cells derived without the use of embryos or fetal tissue
US20030215858A1 (en) 2002-04-08 2003-11-20 Baylor College Of Medicine Enhanced gene expression system
US20030194711A1 (en) 2002-04-10 2003-10-16 Matthew Zapala System and method for analyzing gene expression data
AU2003234498A1 (en) 2002-05-03 2003-11-17 Stowers Institute For Medical Research Method for predicting gene potential and cell commitment
CA2493768A1 (en) 2002-07-23 2004-01-29 Nanodiagnostics, Inc. Embryonic stem cell markers and uses thereof
US7153650B2 (en) 2003-03-13 2006-12-26 Geron Corporation Marker system for preparing and characterizing high-quality human embryonic stem cells
WO2004097005A2 (en) 2003-04-29 2004-11-11 University Of Georgia Research Foundation, Inc. Global analysis of transposable elements as molecular markers of the developmental potential of stem cells
GB0413005D0 (en) 2004-06-11 2004-07-14 Coletica Ligand
GB0504427D0 (en) * 2005-03-03 2005-04-06 Roslin Inst Edinburgh Method for differentiation of stem cells
JP5665272B2 (ja) 2005-10-07 2015-02-04 スピーデクス ピーティーワイ リミテッド 多成分核酸酵素およびそれらの使用方法
US8460928B2 (en) 2005-10-24 2013-06-11 Agency For Science, Technology And Research Methods of specifying mesodermal, endodermal and mesoendodermal cell fates
US8048999B2 (en) 2005-12-13 2011-11-01 Kyoto University Nuclear reprogramming factor
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
US20090227032A1 (en) 2005-12-13 2009-09-10 Kyoto University Nuclear reprogramming factor and induced pluripotent stem cells
JP5813321B2 (ja) 2007-03-23 2015-11-17 ウィスコンシン アラムニ リサーチ ファンデーション 体細胞の再プログラム化
US8962238B2 (en) 2007-04-05 2015-02-24 SpeedDx Pty Ltd Nucleic acid enzymes and complexes and methods for their use
CN105861443A (zh) 2007-04-07 2016-08-17 怀特黑德生物医学研究所 体细胞重编程
EP2164951A2 (en) 2007-05-30 2010-03-24 The General Hospital Corporation Methods of generating pluripotent cells from somatic cells
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US7615374B2 (en) 2007-09-25 2009-11-10 Wisconsin Alumni Research Foundation Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions
AU2008355123B2 (en) 2008-04-21 2014-12-04 Viacyte, Inc. Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
US20100003674A1 (en) 2008-07-03 2010-01-07 Cope Frederick O Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditions
US9453204B2 (en) 2008-07-14 2016-09-27 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of bright/ARID3a function
US8278105B2 (en) 2008-09-09 2012-10-02 University Of Southern California Induction, propagation and isolation of liver progenitor cells
US20120021519A1 (en) 2008-09-19 2012-01-26 Presidents And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
DK2356221T3 (en) 2008-10-24 2019-02-18 Wisconsin Alumni Res Found Pluripotent stem cells obtained by non-viral reprogramming
US20120076762A1 (en) 2009-03-25 2012-03-29 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2011008541A2 (en) 2009-06-29 2011-01-20 The Regents Of The University Of California Molecular markers and assay methods for characterizing cells
WO2011046635A1 (en) 2009-10-14 2011-04-21 The Johns Hopkins University Differentially methylated regions of reprogrammed induced pluripotent stem cells, method and compositions thereof
US8802438B2 (en) 2010-04-16 2014-08-12 Children's Medical Center Corporation Compositions, kits, and methods for making induced pluripotent stem cells using synthetic modified RNAs
WO2011146607A2 (en) 2010-05-18 2011-11-24 President And Fellows Of Harvard College Stable reprogrammed cells
US8945847B2 (en) 2010-05-24 2015-02-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods and kits for ascertaining biosafety of an agent
JP2013545439A (ja) * 2010-09-17 2013-12-26 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 多能性幹細胞の有用性および安全性の特徴決定を行うための機能的ゲノミクスアッセイ
WO2014186766A1 (en) 2013-05-17 2014-11-20 The Broad Institute, Inc. Reprogrammed cells and methods of production and use thereof

Also Published As

Publication number Publication date
US20180251818A1 (en) 2018-09-06
US10626445B2 (en) 2020-04-21
EP3008229B1 (en) 2020-05-27
WO2014200905A2 (en) 2014-12-18
US20160122803A1 (en) 2016-05-05
US11085067B2 (en) 2021-08-10
WO2014200905A3 (en) 2015-03-05
JP2016532435A (ja) 2016-10-20
EP3008229A2 (en) 2016-04-20
EP3008229A4 (en) 2017-03-01

Similar Documents

Publication Publication Date Title
JP6697380B2 (ja) 多能性幹細胞の有用性および安全性を特徴付けるための初期発生ゲノムアッセイ
Janjic et al. Prime-seq, efficient and powerful bulk RNA sequencing
CN103459611B (zh) 对多能干细胞的效用和安全性进行表征的功能基因组学研究
Percharde et al. Hypertranscription in development, stem cells, and regeneration
McDonald et al. Defining the teratoma as a model for multi-lineage human development
Guo et al. Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst
Ortmann et al. Naive pluripotent stem cells exhibit phenotypic variability that is driven by genetic variation
Abeyta et al. Unique gene expression signatures of independently-derived human embryonic stem cell lines
Rinaudo et al. Effects of embryo culture on global pattern of gene expression in preimplantation mouse embryos
Hall et al. Oct4 and LIF/Stat3 additively induce Krüppel factors to sustain embryonic stem cell self-renewal
Robert et al. Combining resources to obtain a comprehensive survey of the bovine embryo transcriptome through deep sequencing and microarrays
WO2016103269A1 (en) Populations of neural progenitor cells and methods of producing and using same
US20230183803A1 (en) Cell characterisation
Szczerbinska et al. A chemically defined feeder-free system for the establishment and maintenance of the human naive pluripotent state
Gu et al. Novel microRNA candidates and miRNA-mRNA pairs in embryonic stem (ES) cells
US12178854B2 (en) Compositions and methods for treating diseases associated with an imprinting defect
Pozzi et al. Genetic deletion of Hesx1 promotes exit from the pluripotent state and impairs developmental diapause
Glenn et al. A Pluripotent Stem Cell Platform for in Vitro Systems Genetics Studies of Mouse Development
CN113106160B (zh) 评估肝谱系细胞成熟度的标志物、双组学试剂盒及构建方法
Gunji et al. Global analysis of the expression patterns of transcriptional regulatory factors in formation of embryoid bodies using sensitive oligonucleotide microarray systems
US10913985B2 (en) Predicting productivity in early cell line development
Class et al. Patent application title: FUNCTIONAL GENOMICS ASSAY FOR CHARACTERIZING PLURIPOTENT STEM CELL UTILITY AND SAFETY Inventors: Kevin C. Eggan (Boston, MA, US) Kevin C. Eggan (Boston, MA, US) Alexander Meissner (Cambridge, MA, US) Christoph Bock (Vienna, AT) Evangelos Kiskinis (Boston, MA, US) Griet Annie Frans Verstappen (Moltsel, BE) Assignees: President and Fellows of Harvard College
Sainz et al. Genome-wide gene expression analysis in mouse embryonic stem cells
Yuan et al. Heart enhancers with deeply conserved regulatory activity are established early in development
Zibetti et al. Lhx2 regulates temporal changes in chromatin accessibility and transcription factor binding in retinal progenitor cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170607

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170607

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180806

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181102

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190717

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191015

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20200319

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200417

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20200424

R150 Certificate of patent or registration of utility model

Ref document number: 6697380

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250